SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
SeaStar Medical (Nasdaq: ICU) said CEO Eric Schlorff will participate in the HC Wainwright 28th Annual Global Investment Conference, held September 14 to 16, 2026, in New York City. The company's presentation will be posted September 11, 2026, at 7:00 am ET on its investor relations site and will remain accessible for 60 days. SeaStar is a commercial-stage medtech whose QUELIMMUNE is the only FDA-approved product for life-threatening AKI in critically ill pediatric patients, and its NEUTRALIZE-AKI pivotal trial is studying the SCD therapy in adults.
Key figures
- Conference dates
- September 14 to 16, 2026
- Presentation release
- September 11, 2026, 7:00 am ET
- Us adults with aki annually
- 200000
- Presentation availability days
- 60
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.